September 13th is National Celiac Awareness Day, meant to raise awareness of the more than three million Americans with celiac disease and to commemorate the birth of Dr. Samuel Gee, who first identified the link between the symptoms of celiac and diet. Despite his pioneering work more than a century ago, researchers are still trying to fully understand this severe autoimmune disease that can damage the small intestines and lead to the inability to absorb nutrients from food. The condition, which runs in families, is challenging to diagnose and impacts only about 1 percent of the population. While there is promising research on the disease, right now the only known treatment is a gluten-free diet. In part because of those dietary recommendations, celiac is sometimes confused with gluten sensitivity, which impacts about 18 million Americans or six times the number of individuals with celiac.

23andMe released a new batch of trait reports that look at whether your DNA indicates you might be tastier to mosquitoes than others, or why you can sing back a musical note or get the heebie-jeebies looking down from great heights, or even why your hair lightens in the sun.

As part of its growing mobile offerings, 23andMe recently released a new app for the iPad that is meant to meet the growing demand from customers who want to access their genetic data while they’re away from their laptop or on the go.

23andMe recently added to its growing list of more than two-dozen Trait Reports. Together, they help illustrate how our genetics influence more than just physical traits like the thickness of our hair, but also food preferences or certain behavioral traits.

23andMe's new G6PD Deficiency* report provides information on whether a customer has a variant called Val68Met, which can lead to defects in an enzyme called glucose-6-phosphate dehydrogenase, or G6PD, that is associated with a form of anemia.

23andMe launched a new page on conditions and to use crowdsourced data on the effectiveness of treatments on 18 difference health conditions, including asthma, depression and migraines.

23andMe's new BRCA1/BRCA2 (Selected Variants) report looks at three variants in the BRCA1 and BRCA2 genes associated with an increased risk of breast, ovarian and prostate cancer. These three variants are most common in people of Ashkenazi Jewish descent, but having one of these variants carries serious risk no matter your ancestry.

Earlier this month 23andMe added a new Carrier Status* report on a serious but rare condition that can lead to excessive insulin production.Known as familial hyperinsulinism (FHI), this congenital disease...

23andMe received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk for its BRCA1/BRCA2 report. The report covers three variants in the BRCA1 and BRCA2 genes associated with increased risk for breast, ovarian, and prostate cancer.

23andMe updates its trait reports, giving them a new look and taking into account genetic and non-genetic factors for results.